Itron

Valuation Analysis

About the Company

Itron en bref

Itron (ITRI) is currently trading at 86,41 € with a market capitalization of 3,8 Md €. The trailing P/E ratio stands at 16.67x, with a forward P/E of 14.67x. The 52-week range spans from 67,43 € to 123,11 €; the current price is 29.8% below the yearly high. Year-over-year revenue growth stands at -7.2%. The net profit margin stands at 11.89%.

💰 Dividende

Itron currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

10 analystes évaluent Itron (ITRI) au consensus : Acheter. L'objectif de cours moyen est de 112,36 €, soit un potentiel de +30.04% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 99,71 € à 130,05 €.

Itron : la thèse d'investissement en détail

Itron (ITRI) operates in the Technology — specifically Scientific & Technical Instruments — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Wall Street consensus sits at Buy with an average price target implying roughly 30.04% upside from current levels — analyst sentiment is firmly constructive. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Le scénario baissier

Revenue is contracting at -7.2% year-over-year — until that trend reverses, valuation is exposed to further downgrades. Short interest sits at 19.64% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valorisation en contexte

With a PEG ratio of 0.88, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity.

À surveiller

• The forward P/E of 14.67x is meaningfully below the trailing 16.67x — analysts expect earnings to step up; the next earnings release is the test.
• The analyst consensus price target implies 30.04% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to market-like volatility, elevated short interest (19.64%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Itron?

Compare top-rated brokers — low fees, trusted providers, fully regulated.